Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 16601-16650 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03322267
Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence
PHASE2
Active, not recruiting
26 participants
Started: Oct 27, 2018 · Completed: Dec 30, 2025
1 condition
2 sponsors
1 location
NCT03375320
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
PHASE3
Active, not recruiting
298 participants
Started: Oct 26, 2018 · Completed: Aug 19, 2026
28 conditions
1 sponsor
436 locations
NCT03455504
Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia
PHASE2
Active, not recruiting
124 participants
Started: Oct 26, 2018 · Completed: Jan 31, 2025
1 condition
1 sponsor
22 locations
NCT03601455
Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer
PHASE2
Active, not recruiting
13 participants
Started: Oct 26, 2018 · Completed: Jan 31, 2027
4 conditions
2 sponsors
1 location
NCT06204523
Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer
N/A
Active, not recruiting
167 participants
Started: Oct 26, 2018 · Completed: Aug 30, 2024
2 conditions
7 sponsors
1 location
NCT03753490
ABC-Scores for Reduction of Stroke and Mortality in Atrial Fibrillation - The ABC-AF Study
NA
Active, not recruiting
3,933 participants
Started: Oct 25, 2018 · Completed: May 31, 2028
1 condition
5 sponsors
1 location
NCT03694145
Predicting Diabetic Retinopathy From Risk Factor Data and Digital Retinal Images
N/A
Active, not recruiting
300 participants
Started: Oct 25, 2018 · Completed: Jul 31, 2025
2 conditions
4 sponsors
3 locations
NCT03740126
Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy
NA
Active, not recruiting
750 participants
Started: Oct 25, 2018 · Completed: Aug 31, 2026
1 condition
3 sponsors
3 locations
NCT03121469
Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer
NA
Active, not recruiting
47 participants
Started: Oct 25, 2018 · Completed: Jun 10, 2025
1 condition
1 sponsor
1 location
NCT03725761
Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
PHASE2
Active, not recruiting
31 participants
Started: Oct 24, 2018 · Completed: Sep 30, 2027
1 condition
3 sponsors
3 locations
NCT03663218
PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT)
NA
Active, not recruiting
35 participants
Started: Oct 24, 2018 · Completed: Mar 31, 2027
1 condition
1 sponsor
1 location
NCT03613532
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
PHASE1
Active, not recruiting
102 participants
Started: Oct 24, 2018 · Completed: Feb 1, 2026
5 conditions
2 sponsors
1 location
NCT03426904
Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer
PHASE3
Active, not recruiting
708 participants
Started: Oct 24, 2018 · Completed: Dec 28, 2030
1 condition
1 sponsor
4 locations
NCT03654768
Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
PHASE2
Active, not recruiting
84 participants
Started: Oct 24, 2018 · Completed: Jul 1, 2028
1 condition
2 sponsors
541 locations
NCT03691714
Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
PHASE2
Active, not recruiting
36 participants
Started: Oct 23, 2018 · Completed: Dec 31, 2024
4 conditions
2 sponsors
1 location
NCT03196011
Traditional Versus Alternative Alignment in TKR
NA
Active, not recruiting
126 participants
Started: Oct 23, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03713983
Treatment Outcomes Among Patients With Prescription Narcotic Drug Use Disorder
N/A
Active, not recruiting
400 participants
Started: Oct 23, 2018 · Completed: Dec 31, 2029
1 condition
2 sponsors
1 location
NCT03643133
Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients
PHASE2
Active, not recruiting
60 participants
Started: Oct 23, 2018 · Completed: Oct 31, 2033
1 condition
1 sponsor
31 locations
NCT03621696
"Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: The Minimalist Trial (MINT)"
PHASE2
Active, not recruiting
63 participants
Started: Oct 23, 2018 · Completed: Mar 10, 2026
1 condition
1 sponsor
1 location
NCT03746184
The Right Treatment for the Right Patient At the Right Time. a Study Following 5,000 Patients with Knee Osteoarthritis
N/A
Active, not recruiting
5,000 participants
Started: Oct 23, 2018 · Completed: Jul 31, 2025
1 condition
5 sponsors
1 location
NCT03674814
Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer
PHASE1
Active, not recruiting
35 participants
Started: Oct 23, 2018 · Completed: Mar 10, 2026
1 condition
3 sponsors
1 location
NCT03668340
AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma
PHASE2
Active, not recruiting
49 participants
Started: Oct 22, 2018 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT03737149
A Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform
NA
Active, not recruiting
10,500 participants
Started: Oct 22, 2018 · Completed: Jul 31, 2025
2 conditions
1 sponsor
30 locations
NCT03018912
Validating the Use of a Subjectively Reported Sleep Vital Sign
NA
Active, not recruiting
1,000 participants
Started: Oct 22, 2018 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT03539744
A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.
PHASE3
Active, not recruiting
265 participants
Started: Oct 22, 2018 · Completed: Nov 30, 2027
1 condition
2 sponsors
180 locations
NCT03742297
Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years
PHASE3
Active, not recruiting
462 participants
Started: Oct 22, 2018 · Completed: Jan 31, 2031
1 condition
1 sponsor
58 locations
NCT03709719
Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia
PHASE2
Active, not recruiting
95 participants
Started: Oct 20, 2018 · Completed: Oct 30, 2028
1 condition
1 sponsor
1 location
NCT03579394
Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
NA
Active, not recruiting
211 participants
Started: Oct 19, 2018 · Completed: Jul 31, 2028
3 conditions
1 sponsor
29 locations
NCT03674619
Cervical Radiculopathy Trial
NA
Active, not recruiting
180 participants
Started: Oct 19, 2018 · Completed: Jan 31, 2028
1 condition
1 sponsor
1 location
NCT03520660
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
PHASE4
Active, not recruiting
121 participants
Started: Oct 19, 2018 · Completed: Dec 31, 2032
3 conditions
1 sponsor
1 location
NCT03617731
Trial on the Effect of Isatuximab to Lenalidomide/Bortezomib/Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma (GMMG HD7)
PHASE3
Active, not recruiting
662 participants
Started: Oct 18, 2018 · Completed: Mar 31, 2027
1 condition
1 sponsor
72 locations
NCT03438552
Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence
NA
Active, not recruiting
57 participants
Started: Oct 18, 2018 · Completed: Nov 30, 2030
1 condition
1 sponsor
12 locations
NCT03637543
Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer
PHASE2
Active, not recruiting
31 participants
Started: Oct 18, 2018 · Completed: Dec 31, 2026
1 condition
3 sponsors
5 locations
NCT03646461
Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC
PHASE2
Active, not recruiting
5 participants
Started: Oct 17, 2018 · Completed: Dec 30, 2025
2 conditions
2 sponsors
1 location
NCT03598608
Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)
PHASE1/PHASE2
Active, not recruiting
174 participants
Started: Oct 17, 2018 · Completed: Jan 16, 2026
3 conditions
1 sponsor
25 locations
NCT03957434
Physiotherapy Treatment for Gynecological Cancer Survivors With Urinary Incontinence
NA
Active, not recruiting
44 participants
Started: Oct 16, 2018 · Completed: Oct 16, 2025
2 conditions
5 sponsors
1 location
NCT03561051
The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study
N/A
Active, not recruiting
700 participants
Started: Oct 16, 2018 · Completed: Jan 1, 2025
3 conditions
5 sponsors
13 locations
NCT03685110
CoreHip - Post Market Clinical Follow-Up Study
N/A
Active, not recruiting
248 participants
Started: Oct 16, 2018 · Completed: Dec 31, 2028
4 conditions
1 sponsor
6 locations
NCT04390906
A Study of Cognitive Changes in Patients Receiving Brain Radiation
N/A
Active, not recruiting
75 participants
Started: Oct 16, 2018 · Completed: Jan 1, 2027
1 condition
2 sponsors
1 location
NCT05170854
The Impact of Liver Cirrhosis on Outcomes in Trauma Patients
N/A
Active, not recruiting
4,774,035 participants
Started: Oct 16, 2018 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT03670680
Efficiency of Lina LibrataTM System
NA
Active, not recruiting
38 participants
Started: Oct 16, 2018 · Completed: Oct 16, 2025
1 condition
1 sponsor
1 location
NCT03982485
Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer
PHASE2
Active, not recruiting
196 participants
Started: Oct 16, 2018 · Completed: Mar 29, 2031
1 condition
1 sponsor
1 location
NCT06400238
Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Expression (MATCH - Subprotocol Z1H)
PHASE2
Active, not recruiting
35 participants
Started: Oct 15, 2018 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT03500458
Impact of Sleep Extension in Adolescents
NA
Active, not recruiting
75 participants
Started: Oct 15, 2018 · Completed: May 31, 2025
3 conditions
2 sponsors
1 location
NCT03471247
CYCLE: A Randomized Clinical Trial of Early In-bed Cycling for Mechanically Ventilated Patients
NA
Active, not recruiting
360 participants
Started: Oct 15, 2018 · Completed: Aug 31, 2024
4 conditions
4 sponsors
16 locations
NCT03635021
Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer
PHASE3
Active, not recruiting
419 participants
Started: Oct 15, 2018 · Completed: Jun 28, 2025
1 condition
2 sponsors
1 location
NCT03708822
Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
PHASE2
Active, not recruiting
48 participants
Started: Oct 15, 2018 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT03697707
Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia
PHASE2
Active, not recruiting
20 participants
Started: Oct 15, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
10 locations
NCT04016870
Project My Heart Your Heart: Pacemaker Reuse
NA
Active, not recruiting
370 participants
Started: Oct 13, 2018 · Completed: Jan 31, 2026
3 conditions
1 sponsor
8 locations
NCT03587311
Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE2
Active, not recruiting
96 participants
Started: Oct 12, 2018 · Completed: Oct 21, 2026
8 conditions
1 sponsor
23 locations
Previous
1
More pages
330
331
332
333
334
335
336
More pages
431
Next